TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T63414	P2X purinoceptor 7	D02LMZ	ATPase	Phase 2	5957	C10H16N5O13P3	507.18	C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N	EC50 = 780000 nM	Non binder
T63414	P2X purinoceptor 7	B3PYB9	N'-(2-Chlorophenyl)pentacyclo[6.4.0.02,10.03,7.04,9]dodecane-8-carbohydrazide	Investigative	137644370	C19H21ClN2O	328.8	C1CC2C3C1C4C2(C5C3C4CC5)C(=O)NNC6=CC=CC=C6Cl	IC50 = 933000 nM	Non binder
T63414	P2X purinoceptor 7	BHS4I3	N'-[2-(Trifluoromethyl)phenyl]pentacyclo[6.4.0.02,10.03,7.04,9]dodecane-8-carbohydrazide	Investigative	137652052	C20H21F3N2O	362.4	C1CC2C3C1C4C2(C5C3C4CC5)C(=O)NNC6=CC=CC=C6C(F)(F)F	IC50 = 366000 nM	Non binder
T63414	P2X purinoceptor 7	BW0CZ4	N'-[2-Chloro-4-(trifluoromethyl)phenyl]pentacyclo[6.4.0.02,10.03,7.04,9]dodeca-5,11-diene-8-carbohydrazide	Investigative	137632064	C20H16ClF3N2O	392.8	C1=CC2C3C1C4C2(C5C3C4C=C5)C(=O)NNC6=C(C=C(C=C6)C(F)(F)F)Cl	IC50 = 1557000 nM	Non binder